Tuesday, April 23, 2024
Home Tags Albireo

Tag: Albireo

Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

0
BOSTON, May 07, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News